MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$52,599K
Interest income
$3,819K
Net operating loss
-$56,385K
Other (expense)
income, net
-$33K
Total operating
expenses
$56,385K
Research and development
$32,672K
General and
administrative
$23,713K
Back
Back
Income Statement
source: myfinsight.com
TENAX THERAPEUTICS, INC. (TENX)
TENAX THERAPEUTICS, INC. (TENX)